Ahmed A - Search Results

1

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Among authors: ahmed a. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

2

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Among authors: ahmed a. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

3

Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells.

Bonnotte B, Gough M, Phan V, Ahmed A, Chong H, Martin F, Vile RG. Bonnotte B, et al. Among authors: ahmed a. Cancer Res. 2003 May 1;63(9):2145-9. Cancer Res. 2003. PMID: 12727832

4

Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.

Sanchez-Perez L, Kottke T, Diaz RM, Ahmed A, Thompson J, Chong H, Melcher A, Holmen S, Daniels G, Vile RG. Sanchez-Perez L, et al. Among authors: ahmed a. Cancer Res. 2005 Mar 1;65(5):2009-17. doi: 10.1158/0008-5472.CAN-04-3216. Cancer Res. 2005. PMID: 15753401

5

Macrophages orchestrate the immune response to tumor cell death.

Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. Gough MJ, et al. Among authors: ahmed a. Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761

6

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.

Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R. Emiliusen L, et al. Among authors: ahmed a. Gene Ther. 2001 Jul;8(13):987-98. doi: 10.1038/sj.gt.3301470. Gene Ther. 2001. PMID: 11438833

7

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.

Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R. Ahmed A, et al. Gene Ther. 2003 Sep;10(19):1663-71. doi: 10.1038/sj.gt.3302064. Gene Ther. 2003. PMID: 12923565

8

Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.

Sanchez-Perez L, Gough M, Qiao J, Thanarajasingam U, Kottke T, Ahmed A, Thompson JM, Maria Diaz R, Vile RG. Sanchez-Perez L, et al. Among authors: ahmed a. Gene Ther. 2007 Jul;14(13):998-1009. doi: 10.1038/sj.gt.3302935. Epub 2007 Apr 19. Gene Ther. 2007. PMID: 17443216

9

The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles.

Kottke T, Qiao J, Diaz RM, Ahmed A, Vroman B, Thompson J, Sanchez-Perez L, Vile R. Kottke T, et al. Among authors: ahmed a. Gene Ther. 2006 Aug;13(15):1166-77. doi: 10.1038/sj.gt.3302722. Epub 2006 Apr 20. Gene Ther. 2006. PMID: 16625245

10

Dendritic cells for the immunotherapy of cancer.

Melcher A, Bateman A, Harrington K, Ahmed A, Gough M, Vile R. Melcher A, et al. Among authors: ahmed a. Clin Oncol (R Coll Radiol). 2002 Jun;14(3):185-92. doi: 10.1053/clon.2001.0038. Clin Oncol (R Coll Radiol). 2002. PMID: 12109820 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,588 results

Search Page

Filters